Literature DB >> 35004952

Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future.

Ting-Yao Wang1, Jacob George2, Ming-Hua Zheng3,4,5.   

Abstract

Entities:  

Year:  2021        PMID： 35004952      PMCID： PMC8683909          DOI： 10.21037/hbsn-21-352

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  20 in total

1.  Clinical utility of the MAFLD definition.

Authors:  Kenneth I Zheng; Dan-Qin Sun; Yi Jin; Pei-Wu Zhu; Ming-Hua Zheng
Journal:  J Hepatol       Date:  2020-12-24       Impact factor: 25.083

2.  Non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis.

Authors:  Yu-Jie Zhou; Kenneth I Zheng; Giovanni Targher; Christopher D Byrne; Ming-Hua Zheng
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-01

3.  Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists.

Authors:  Yasser Fouad; Ahmed Gomaa; Nady Semida; Wael Abdel Ghany; Dina Attia
Journal:  J Hepatol       Date:  2021-02-11       Impact factor: 25.083

4.  Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population.

Authors:  Stefano Ciardullo; Gianluca Perseghin
Journal:  Liver Int       Date:  2021-03-03       Impact factor: 5.828

5.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 6.  Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.

Authors:  Gamal Shiha; Khalid Alswat; Maryam Al Khatry; Ala I Sharara; Necati Örmeci; Imam Waked; Mustapha Benazzouz; Fuad Al-Ali; Abd Elkhalek Hamed; Waseem Hamoudi; Dina Attia; Moutaz Derbala; Mohamed Sharaf-Eldin; Said A Al-Busafi; Samy Zaky; Khaled Bamakhrama; Nazir Ibrahim; Yousef Ajlouni; Meriam Sabbah; Mohsen Salama; Amir Anushiravani; Nawel Afredj; Salma Barakat; Almoutaz Hashim; Yasser Fouad; Reham Soliman
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-09

7.  Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Jean Woo; Jill M Abrigo; Carmen Ka-Man Chan; Sally She-Ting Shu; Julie Ka-Yu Leung; Angel Mei-Ling Chim; Alice Pik-Shan Kong; Grace Chung-Yan Lui; Henry Lik-Yuen Chan; Winnie Chiu-Wing Chu
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-31       Impact factor: 11.382

8.  Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.

Authors:  Madunil Anuk Niriella; Dileepa Senajith Ediriweera; Anuradhani Kasturiratne; Shamila Thivanshi De Silva; Anuradha Supun Dassanayaka; Arjuna Priyadarshin De Silva; Norihiro Kato; Arunasalam Pathmeswaran; Ananda Rajitha Wickramasinghe; Hithanadura Janaka de Silva
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

9.  Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.

Authors:  Jiaye Liu; Ibrahim Ayada; Xiaofang Zhang; Ling Wang; Yang Li; Tianfu Wen; Zhongren Ma; Marco J Bruno; Robert J de Knegt; Wanlu Cao; Maikel P Peppelenbosch; Mohsen Ghanbari; Zhihui Li; Qiuwei Pan
Journal:  Clin Gastroenterol Hepatol       Date:  2021-02-20       Impact factor: 11.382

10.  NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III.

Authors:  Qi Huang; Xiantong Zou; Xin Wen; Xianghai Zhou; Linong Ji
Journal:  Front Med (Lausanne)       Date:  2021-07-01
View more
  2 in total

Review 1.  Association of metabolic dysfunction-associated fatty liver disease with kidney disease.

Authors:  Ting-Yao Wang; Rui-Fang Wang; Zhi-Ying Bu; Giovanni Targher; Christopher D Byrne; Dan-Qin Sun; Ming-Hua Zheng
Journal:  Nat Rev Nephrol       Date:  2022-01-10       Impact factor: 28.314

2.  Surgical treatment of secondary hyperparathyroidism combined with Sagliker syndrome caused by chronic renal failure: a case report.

Authors:  Yi Pang; Xiangchao Meng
Journal:  Gland Surg       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.